HT941026AE002
Blanket Purchase Agreement
Overview
Government Description
BPA for Pluvicto and Lutathera Injection
Awarding / Funding Agency
Pricing
Order Dependent (IDV Only)
Set Aside
None
Extent Competed
Not Reported
Multiple / Single Award
Single Award
Who Can Use
Single Agency
Individual Order Limit
$500,000
Vehicle Ceiling
$5,000,000 (0% Used)
Related Opportunity
Novartis Pharmaceuticals Corporation was awarded
Blanket Purchase Agreement HT941026AE002 (HT9410-26-A-E002)
by
Defense Health Agency
in March 2026.
The BPA
has a duration of 5 years and
was awarded
through solicitation Pluvicto and Lutathera 5 Year BPA
full & open
with
NAICS 325412 and
PSC 6505
via undisclosed acquisition procedures.
The total ceiling is $5,000,000, of which 0% has been used.
Status
(Open)
Modified 1/29/26
Period of Performance
3/1/26
Start Date
3/1/31
Ordering Period End Date
Task Order Obligations
$0
Total Obligated
$0
Current Award
$0
Potential Award
Opportunity Lifecycle
Procurement history for HT941026AE002
Transaction History
Modifications to HT941026AE002
People
Suggested agency contacts for HT941026AE002
Competition
Number of Bidders
Not Applicable
Solicitation Procedures
Not Applicable
Evaluated Preference
None
Commercial Item Acquisition
Commercial Item Procedures Not Used
Simplified Procedures for Commercial Items
None
Other Categorizations
Subcontracting Plan
None
Cost Accounting Standards
Yes
Business Size Determination
Large Business
DoD Claimant Code
None
Awardee UEI
NG61ZA8TADW3
Awardee CAGE
04520
Agency Detail
Awarding Office
HT9410 DEFENSE HEALTH AGENCY HCD WEST
Funding Office
HT0500 NAV MED CTR SAN DIEGO CA - MM
Created By
cha-on.p.gordon2.civ@health.mil
Last Modified By
ecwm.soa@sa97dh.dha
Approved By
ecwm.soa@sa97dh.dha
Legislative
Legislative Mandates
None Applicable
Awardee District
NJ-11
Senators
Robert Menendez
Cory Booker
Cory Booker
Representative
Mikie Sherrill
Last Modified: 1/29/26